Publicaciones en las que colabora con María del Carmen Dios Vieitez (18)

2016

  1. Cyclosporine A lipid nanoparticles for oral administration: Pharmacodynamics and safety evaluation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 101, pp. 112-118

  2. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 196-198

  3. Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 500, Núm. 1-2, pp. 154-161

  4. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy

    Journal of Controlled Release, Vol. 225, pp. 269-282

2015

  1. Lipid nanoparticles for cyclosporine a administration: Development, characterization, and in vitro evaluation of their immunosuppression activity

    International Journal of Nanomedicine, Vol. 10, pp. 6541-6553

2014

  1. Development and validation of a HPLC method for the determination of cyclosporine a in new bioadhesive nanoparticles for oral Administration

    Indian Journal of Pharmaceutical Sciences, Vol. 76, Núm. 2, pp. 132-137

  2. Influence of cyclodextrin derivatives on in vitro release of cyclosporine A from poly(anhydride) nanoparticles

    Journal of Nanopharmaceutics and Drug Delivery, Vol. 2, Núm. 2, pp. 161-168

2013

  1. Ultra high performance liquid chromatography-tandem mass spectrometry method for cyclosporine a quantification in biological samples and lipid nanosystems

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 927, pp. 164-172

2012

  1. Lipid nanoparticles for cancer therapy: State of the art and future prospects

    Expert Opinion on Drug Delivery, Vol. 9, Núm. 10, pp. 1245-1261

2004

  1. Hematological response of topotecan in tumor-bearing rats: Modeling of the time course of different cellular populations

    Pharmaceutical Research, Vol. 21, Núm. 4, pp. 567-573

  2. High-performance liquid-chromatographic determination of rifampicin in plasma and tissues

    Journal of Chromatography A, Vol. 1031, Núm. 1-2, pp. 289-294

  3. Rapid and simple determination of doxycycline in serum by high-performance liquid chromatography: Application to particulate drug delivery systems

    Journal of Chromatography A, Vol. 1031, Núm. 1-2, pp. 295-301

2003

  1. Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: Role of cytochrome P450 2D activity

    Journal of Pharmacology and Experimental Therapeutics, Vol. 305, Núm. 2, pp. 710-718

2001

  1. Pharmacokinetic/pharmacodynamic modeling of antipyretic and anti-inflammatory effects of naproxen in the rat

    Journal of Pharmacology and Experimental Therapeutics, Vol. 297, Núm. 1, pp. 198-205

2000

  1. Comparative pharmacokinetics, tissue distributions, and effects on renal function of novel polymeric formulations of amphotericin B and amphotericin B-deoxycholate in rats

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 4, pp. 898-904

1997

  1. Determination of a new hypoxia selective agent from 2-quinoxalinecarbonitrile 1,4-di-N-oxides in plasma by high performance liquid chromatography

    Arzneimittel-Forschung/Drug Research, Vol. 47, Núm. 9, pp. 1044-1046

  2. Quantitative analysis of temazepam in plasma by capillary gas chromatography: Application to pharmacokinetic studies in rats

    Chromatographia, Vol. 44, Núm. 3-4, pp. 169-171

1995

  1. CONCENTRATIONES URINARIAS DE FOSFOMICINA TRAS LA ADMINISTRACION DE UNA DOSIS UNICA DE FOSFOMICINA TROMETAMOL: APLICATION A LA TERAPIA MONODOSIS DE LAS INFECCIONES URINARIAS

    Revista Espanola de Quimioterapia, Vol. 8, Núm. 3, pp. 229-232